HUL Share Price in Focus; Completes Nutritionalab Divestment

Hindustan Unilever Limited (HUL) has announced the completion of its divestment of Nutritionalab, marking a strategic portfolio move within its health and wellbeing segment. 

The company also approved the acquisition of the remaining stake in Zywie Ventures Private Limited. These developments follow HUL’s recent plans to invest in expanding manufacturing capacity across its premium product categories.

HUL Completes Divestment of Nutritionalab

In a regulatory filing, Hindustan Unilever stated that it has completed the sale of its entire shareholding in Nutritionalab. The transaction was carried out in accordance with the terms agreed upon between the involved parties.

The company noted that the divestment follows its earlier disclosure made to the stock exchanges on 12 February 2026.

Board Approves Acquisition of Remaining Stake in Zywie Ventures

In a separate development disclosed last month, HUL’s board approved the purchase of the remaining 49% stake in Zywie Ventures Private Limited. The transaction is valued at approximately ₹824 crore and will be executed under a pre-agreed valuation framework.

The acquisition will increase HUL’s ownership in the company, further strengthening its presence in the health and wellbeing segment.

Expansion in Health and Wellbeing Portfolio

HUL entered the health and wellbeing segment in 2022 through strategic investments. These included the acquisition of a majority stake in OZiva and the purchase of a 19.8% stake in Wellbeing Nutrition.

The company has been gradually expanding its footprint in this category as part of its broader portfolio strategy.

Manufacturing Capacity Expansion Plans

Earlier, on 18 February 2026, HUL announced plans to invest around ₹2,000 crore over the next two years. The investment is aimed at expanding manufacturing capacity across premium product categories.

The planned expansion will focus on segments such as beauty and wellbeing products as well as home care liquids.

HUL Share Price Performance

Shares of Hindustan Unilever Limited were trading lower on 5 March 2026. The stock was quoted at ₹2,236.00, down ₹25.30 or 1.12% from the previous close of ₹2,261.30.

During the trading session, the share opened at ₹2,275.50 and moved between an intraday high of ₹2,277.80 and a low of ₹2,230.60.

Read More: Tata Steel, SAIL and Hindalco fall as Nifty Metal drops 4% amid West Asia tensions.

Conclusion

The completion of the Nutritionalab divestment and the planned acquisition of Zywie Ventures reflect Hindustan Unilever’s ongoing portfolio adjustments within the health and wellbeing segment. Alongside these developments, the company’s planned investment in manufacturing capacity indicates continued focus on expanding its presence in selected premium product categories.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks. Read all related documents carefully before investing.